Zel Skin & Laser Specialists is one of the first centers in Minnesota to offer the Latisse prescription eye thickener to patients. Approved by the U.S. Food and Drug Administration in Dec. 2008, Latisse is a novel treatment for hypotrichosis of the eyelashes, a condition of inadequate or not enough eyelashes, and is the first and only science-based treatment approved by the FDA to enhance eyelashes by increasing the length, thickness and darkness of lashes.
The active ingredient in Latisse is bimatroprost, the same ingredient in Allergan’s treatment for glaucoma called Lumigan. Patients taking Lumigan discovered a side of effect of the drug to be eyelash growth, which prompted the company to study it for the new use. “We are seeing tremendous interest in a product that can actually grow eyelashes,” said Dr. Zelickson.
Latisse is a once–a–day prescription treatment that is applied to the base of the upper eyelash with a sterile, disposable applicator. Latisse users should expect to see longer, fuller and darker eyelashes in as little as eight weeks, with full results expected in 16 weeks on average. Regular daily treatment is required to maintain the benefits of Latisse. When the application is stopped, the eyelashes gradually return to the state they were before treatment. Latisse retails for $120 and requires a prescription. If you are interested in this exciting new product, please call 952–929–8888 to schedule a consult.